These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 787661)

  • 41. Azathioprine dose escalation in inflammatory bowel disease.
    Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
    Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunomodulator therapy of inflammatory bowel disease.
    Baert F; Rutgeerts P
    Acta Clin Belg; 1997; 52(5):251-7. PubMed ID: 9489118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
    Mossop H; Davies P; Murphy MS
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Is there any interest to dose the azathioprine's metabolites during inflammatory bowel diseases?].
    Melaouhia S; Fékih M; Ferchichi H; Bouissorra H; Ben Mustapha N; Boubaker J; Filali A; Lakhal M; Klouz A
    Therapie; 2013; 68(5):313-20. PubMed ID: 24225042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
    Wisch N; Korelitz BI
    Surg Clin North Am; 1972 Aug; 52(4):961-9. PubMed ID: 5047533
    [No Abstract]   [Full Text] [Related]  

  • 48. Herpes simplex virus meningoencephalitis in a patient with Crohn's disease on azathioprine therapy.
    Robineau O; Enrico J; Lemaire X; Poissy J; Legout L; Senneville E; Colombel JF; Yazdanpanah Y
    Am J Gastroenterol; 2010 Jan; 105(1):240-1. PubMed ID: 20054331
    [No Abstract]   [Full Text] [Related]  

  • 49. Medical management of specific clinical presentations.
    Bitton A; Peppercorn MA
    Gastroenterol Clin North Am; 1995 Sep; 24(3):541-58. PubMed ID: 8809235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunosuppressive therapy].
    Keitel W
    Z Arztl Fortbild (Jena); 1971 Aug; 65(16):847-50. PubMed ID: 5146540
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute myeloid leukemia after one month of azathioprine therapy in a Crohn's disease patient.
    Kallel L; Naijaa N; Fekih M; Frikha I; Boubaker J; Bellaaj H; Romdhane NB; Filali A
    J Clin Gastroenterol; 2010 Oct; 44(9):660. PubMed ID: 20216428
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn's disease treated by azathioprine: a series of four cases.
    N'Guyen Y; Baumard S; Salmon JH; Lemoine L; Lévêque N; Servettaz A; Jaussaud R; Strady C; Andreoletti L
    Inflamm Bowel Dis; 2011 Sep; 17(9):E116-8. PubMed ID: 21710533
    [No Abstract]   [Full Text] [Related]  

  • 53. [News on Azathioprine in IBD].
    Teich N
    Z Gastroenterol; 2013 Oct; 51(10):1195-6. PubMed ID: 24122383
    [No Abstract]   [Full Text] [Related]  

  • 54. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
    Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute generalized exanthematous pustulosis induced by azathioprine in a patient with ulcerative colitis.
    Avgerinos A; Giannikaki E; Krüger-Krasagakis S; Koutroubakis IE
    Am J Gastroenterol; 2011 May; 106(5):1005-7. PubMed ID: 21540908
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of azathioprine in IBD: modern aspects of an old drug.
    Louis E; Irving P; Beaugerie L
    Gut; 2014 Nov; 63(11):1695-9. PubMed ID: 24943205
    [No Abstract]   [Full Text] [Related]  

  • 58. Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease.
    Present DH
    Am J Gastroenterol; 1993 May; 88(5):627-30. PubMed ID: 8480721
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
    Peyrin-Biroulet L; Oussalah A; Roblin X; Sparrow MP
    Aliment Pharmacol Ther; 2011 Mar; 33(6):707-13. PubMed ID: 21251032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Azathioprine].
    Sasaki M; Fujiyama Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():692-9. PubMed ID: 15954431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.